Serum placental growth factor (sPlGF) levels were higher in patients with CTD-PAH vs. in those with IPAH and healthy controls, and there was a correlation between sPlGF and 6MWD, BNP levels and the World Health Organisation functional class (WHO-FC). This evidence concerns the gene PGF and pulmonary arterial hypertension.